Growth Metrics

Enovis (ENOV) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 1,600.69%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 1,600.69%
Dec 31, 2025 0.24%
Oct 3, 2025 54.18%
Jul 4, 2025 514.55%
Apr 4, 2025 95.59%
Dec 31, 2024 29.11%
Sep 27, 2024 72.69%
Jun 28, 2024 -72.34%
Mar 29, 2024 -584.86%
Dec 31, 2023 290.26%
Sep 29, 2023 59.78%
Jun 30, 2023 212.91%
Mar 31, 2023 151.70%
Dec 31, 2022 -137.37%
Sep 30, 2022 -80.02%
Jul 1, 2022 -131.76%
Apr 1, 2022 -117.09%
Dec 31, 2021 -25.30%
Oct 1, 2021 21.54%
Jul 2, 2021 111.90%
Apr 2, 2021 50.07%
Dec 31, 2020 97.55%
Oct 2, 2020 44.47%
Jul 3, 2020 -55.29%
Apr 3, 2020 177.78%
Dec 31, 2019 -48.07%
Sep 27, 2019 -17.62%
Jun 28, 2019 127.76%
Mar 29, 2019 -2,620.66%
Dec 31, 2018 20.64%
Sep 28, 2018 316.20%
Jun 29, 2018 -37.55%
Mar 30, 2018 -106.58%
Dec 31, 2017 -28.28%
Sep 29, 2017 -64.50%
Jun 30, 2017 42.20%
Mar 31, 2017 160.41%
Dec 31, 2016 -4.32%
Sep 30, 2016 -46.71%
Jul 1, 2016 -40.66%
Apr 1, 2016 856.88%
Dec 31, 2015 -17.67%
Sep 25, 2015 -48.15%
Jun 26, 2015 -33.80%
Mar 27, 2015 96.94%
Dec 31, 2014 5.08%
Sep 26, 2014 62.56%
Jun 27, 2014 5.06%
Mar 28, 2014 -399.74%
Dec 31, 2013 6.46%
Sep 27, 2013 150.47%
Jun 28, 2013 26.68%
Mar 29, 2013 87.72%
Dec 31, 2012 964.18%
Sep 28, 2012 204.64%
Jun 29, 2012 229.96%
Mar 30, 2012 -2,419.14%
Dec 31, 2011 -41.97%
Sep 30, 2011 68.57%